# SAPIEN 3 Ultra EU PMS

> **NCT04860752** · — · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 500 (actual)

## Conditions studied

- Aortic Stenosis
- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Transcatheter Aortic Valve Implantation (TAVI)

## Key facts

- **NCT ID:** NCT04860752
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-20
- **Primary completion:** 2024-07-22
- **Final completion:** 2024-07-22
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860752, "SAPIEN 3 Ultra EU PMS". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04860752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*